RARE vs SHC · rev $350.0M vs P/E 38, rev $601.4M
Ultragenyx (RARE) versus Sotera Health Co (SHC) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Sotera Health Co (SHC) is a diagnostics & research company listed on NASDAQ.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Latest reported SHC revenue for 2026-06-30 was $601.4M. Net income was $80.2M. SHC currently screens at market cap $4.41B and trailing P/E 37.7.
RARE currently screens at market cap $2.79B. SHC currently screens at market cap $4.41B and trailing P/E 37.7.
Not investment advice. Open the RARE and SHC stock pages for the full models.
Not investment advice.